GI DYNAMICS, INC.

BOSTON, MA · Medtech · Public

Endoscopic medical device that modifies the small intestine to treat type 2 diabetes by addressing metabolic root causes

Claim this profile

Follows are private to you and power your alerts

Updated · morphicmedical.com

Sector
Medtech
Headquarters
BOSTON, MA
Latest Form D
$2.2M, Oct 2018
Total capital
$90.1M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$90.1M
5 Form D · last Oct 2018
97 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
18
22 pending · first 2015
Rank in peer group#120 of 1112

Capital timeline

20102012201420162018FEDERAL ↑EQUITY ↓Cumulative $90.1M1st Form D$15M2nd Form D$37.5M3rd Form D$34.8M4th Form D$699K
20102012201420162018FEDERAL ↑EQUITY ↓Cumulative $90.1M3rd Form D$34.8M

Latest events

  • Private capital raisedForm D · SEC · 5th filing$2.2M
  • Private capital raisedForm D · SEC · 4th filing$699K
  • Private capital raisedForm D · SEC · 3rd filing$34.8M
  • Private capital raisedForm D · SEC · 2nd filing$37.5M
  • Private capital raisedForm D · SEC · 1st filing$15M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#120 · top 11%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Scott SchorerResearcherExecutive OfficerLinked by 3 patents
  • Andy A. LevineExecutive Officer, DirectorNamed in SEC Form D filings
  • Anne J. KeatingDirectorNamed in SEC Form D filings
  • Brian A. HalakDirectorNamed in SEC Form D filings
  • Daniel MooreDirectorNamed in SEC Form D filings
  • Graham John BradleyDirectorNamed in SEC Form D filings
Show all 15 people
  • Jack J. MeyerDirectorNamed in SEC Form D filings
  • Jonathan A. OsgoodDirectorNamed in SEC Form D filings
  • Juliet ThompsonDirectorNamed in SEC Form D filings
  • Kedir A. KadhiresanDirectorNamed in SEC Form D filings
  • Michael J. CarusiDirectorNamed in SEC Form D filings
  • Robert W. CraneExecutive OfficerNamed in SEC Form D filings
  • Stuart A. RandleExecutive Officer, DirectorNamed in SEC Form D filings
  • Stuge OernDirectorNamed in SEC Form D filings
  • Timothy BarberichDirectorNamed in SEC Form D filings

What it has protected

USPTO · 18 granted of 40
Show all 40 patent records
  • Binx HealthSimilar federal contract value in Medtech · null in contracts
  • GENOMIND, INC.Similar federal contract value in Medtech · null in contracts
  • SunBird BioSimilar federal contract value in Medtech · null in contracts
  • Axon Therapies Inc.Similar federal contract value in Medtech · null in contracts
  • Apreo Health, Inc.Similar federal contract value in Medtech · null in contracts
  • METRITRACK, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .